- Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes | Start Date 22-06-2016 | End Date |
Abbreviated Name | Abbreviated Name Paliperidone 350mg/1.75ml prolonged-release inj pf syringes | Start Date 22-06-2016 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.75
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Prolonged-release suspension for injection
- Ontology Form/Route
- suspensioninjectionprolonged-release.intramuscular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N05AX13
BNF | Start Date | End Date |
---|---|---|
Current BNF 04020200 | Start Date 04-04-2022 | End Date |
Previous BNF 04020200 | Start Date 31-07-2017 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
32879111000001104 | 22-06-2016 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Paliperidone palmitate | Based on Base Substance | Paliperidone | 200 mg | 1 ml |
Name
Paliperidone palmitate
Basis of strength description
Based on Base Substance
BOSS
Paliperidone
Strength and UOM (Nmr)
200
Strength and UOM (Dmr)
1
Parent Products
-
VTMPaliperidone
-
VMP(Current) Paliperidone 350mg/1.75ml prolonged-...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 pre-filled disposable injection | 94221 | Part VIIIA Category C |